Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Interest & Investment Income: 2015-2024

Historic Interest & Investment Income for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $14.1 million.

  • Editas Medicine's Interest & Investment Income fell 48.13% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year decrease of 56.38%. This contributed to the annual value of $14.1 million for FY2024, which is 19.95% down from last year.
  • Editas Medicine's Interest & Investment Income amounted to $14.1 million in FY2024, which was down 19.95% from $17.6 million recorded in FY2023.
  • In the past 5 years, Editas Medicine's Interest & Investment Income registered a high of $17.6 million during FY2023, and its lowest value of $607,000 during FY2021.
  • Its 3-year average for Interest & Investment Income is $12.4 million, with a median of $14.1 million in 2024.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first tumbled by 76.70% in 2021, then skyrocketed by 809.06% in 2022.
  • Editas Medicine's Interest & Investment Income (Yearly) stood at $2.6 million in 2020, then crashed by 76.70% to $607,000 in 2021, then surged by 809.06% to $5.5 million in 2022, then skyrocketed by 218.34% to $17.6 million in 2023, then decreased by 19.95% to $14.1 million in 2024.